Can hsCRP help with Wechseljahre?

The question of whether hsCRP (high-sensitivity C-reactive protein) can help with menopause (Wechseljahre) is misleading. hsCRP is an inflammatory marker, not a treatment. During menopause, cardiovascular risk increases, and hsCRP can serve as a risk marker for heart disease—but not specifically for menopausal symptoms like hot flashes or mood changes. The provided context documents contain no direct studies linking hsCRP to menopause. There is mechanistic evidence that anti-inflammatory diets (e.g., Mediterranean) may lower hsCRP and reduce cardiovascular risk in menopause, but this is not a specific 'help' for menopause itself. The evidence is mechanistic and based on general inflammation, not clinical outcomes for menopause. Consumers should not view hsCRP as a standalone tool for menopause assessment; it is a supplementary biomarker in cardiovascular prevention. Marketing that promotes hsCRP as a 'menopause test' is misleading.